Budiodarone is an investigational antiarrhythmic agent and a structural analogue of amiodarone developed for the management of cardiac arrhythmias, particularly paroxysmal atrial fibrillation. This category… Read more











Budiodarone is an investigational antiarrhythmic agent and a structural analogue of amiodarone developed for the management of cardiac arrhythmias, particularly paroxysmal atrial fibrillation. This category encompasses a range of high-quality reference standards essential for pharmaceutical research and development, including the active pharmaceutical ingredient, its related impurities, and stable isotope-labelled compounds. Laboratories utilize these materials for rigorous impurity profiling, method validation, and routine quality control processes. By incorporating these well-characterized reference standards and isotopically labelled analogs—such as deuterium-labelled derivatives—analytical chemists can achieve the precise quantification and structural verification necessary for drug stability studies and regulatory compliance. These compounds provide the critical support required to maintain high standards in the analytical assessment and characterization of this antiarrhythmic therapeutic throughout the drug development lifecycle.